Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × dalpiciclib × Breast × Clear all

Phase

Status

Recruiting 15 Not yet recruiting 9 Unknown 8 Terminated 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Fluorodeoxyglucose F18 3 Letrozole 2 Drug Therapy 2 sacituzumab govitecan 1 ribociclib 1 exemestane 1 dalpiciclib 1 Zoledronic Acid 1 Vitamin D 1 Transurethral Resection of Bladder 1 Therapeutics 1 Tamoxifen 1 Synbiotics 1 Surgical Procedures, Operative 1 Self-Help Groups 1 Resistance Training 1 Relaxation Therapy 1 Radiotherapy 1 Radiation 1 Prebiotics 1 Neoadjuvant Therapy 1 Mastectomy 1 Mannitol 1 Mammography 1 Interviews as Topic 1 Exercise 1 Educational Status 1 Diagnostic Imaging 1 Cyclophosphamide 1 Combined Modality Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06650748 2026-03-17

NeoMARS

Peking University

Phase 2 Enrolling by invitation

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡